PROTHENA CORPORATION PLC (PRTA)
Currency USD
Company Overview
Prothena Corp. plc, being a clinical-stage neuroscience company, focused on the development of novel therapeutic therapies for life-threatening diseases. Its wholly owned programs include birtamimab for the potential treatment of AL amyloidosis, PRX004 for the potential treatment of ATTR amyloidosis and a portfolio of programs for the potential treatment of Alzheimer's disease including PRX012 that targets A'.'Prothena is also developing candidates in collaboration with bigwigs like Roche and Bristol-Myers Squibb. These programs include prasinezumab, in collaboration with Roche for the potential treatment of Parkinson's disease and other related synucleinopathies, and programs that target tau, TDP-43 and an undisclosed target in collaboration with Bristol-Myers Squibb for the potential treatment of Alzheimer's disease, amyotrophic lateralsclerosis, etc. It sold PRX004 and the broader ATTR amyloidosis program to Novo Nordisk. It derives revenues from license, development & commercialization agreements.
Contact Details
- Address
- 77 SIR JOHN ROGERSON`S QUAY BLOCK C GRAND CANAL DOCKLANDS
- City
- DUBLIN
- State
- L2
- Country
- IRL
- Zip Code
- D02 VK60
- Phone Number
- 011-353-1236-2500
- Website
- -
Financial Highlights
-
Day Range
The price range a stock has traded at during the most recent trading period.
-
--
-
5 Day Range
The price range a stock has traded at during the previous 5 days.
-
--
-
3 Month Range
The price range a stock has traded at during the previous 3 months.
-
--
-
52 Week Range
The price range a stock has traded at during the previous 52 weeks.
-
--
-
Previous Close
The closing price of a stock from the previous day.
-
-
Open
The price of the stock at the start of today’s market opening.
-
-
Bid
The amount of money a trader is willing to pay per share for a given stock.
-
x-
-
Ask
The amount of money a seller wants per share of a given stock.
-
x-
-
Volume
The number of shares traded in a given period. This number illustrates the active interest in the stock at any time.
-
-
Avg. Volume
The average number of shares traded in a given day.
-
-
Dividend Yield
A company's annual dividend expressed as a percentage of its current stock price.
-
-
Recent Dividend
The value a shareholder receives from a company they are invested in for holding their shares.
-
-
Beta
A measurement of the stock’s volatility in comparison to the market as a whole.
-
Shareholding
-
Shares Outstanding
Number of shares currently held by investors, including restricted shares owned by the company's officers and insiders.
-
-
Insider Shareholders
The percentage of shares owned by any officer or board director of the company, including their related or affiliated individuals, families, entities and trusts.
-
-
Institutional Shareholders
The percentage of shares owned by an institution such as a mutual fund, bank or insurance company.
-
-
Market Cap
The market value of a company’s outstanding shares. It is used as a measurement tool to determine how large a company is.
-
-
Revenue TTM
The amount of money a company has made for the trailing twelve-month period.
-
-
Net Income TTM
A measurement of how much profit they are retaining for the trailing twelve-month period.
-
-
P/E Ratio
The Price to Earnings (P/E) ratio, is calculated by dividing the stock's most recent share price by the sum of the diluted earnings per share.
-
-
EPS TTM
Earnings Per Share (EPS) TTM is a company's profit for the trailing twelve-month period divided by its number of common outstanding shares.
-
-
1 Year Return
A measurement of how much the stock has increased or decreased in the last year.
-
There is no stock data currently available for this time period, please select another option.
Please wait, gathering market data...